abstract |
The present invention is broadly related to the field of stabilization of gonadotropin formulations, particularly liquid formulations of gonadotropins. This stabilization can be achieved by a combination of specific excipients, preferably arginine and methionine. In a preferred embodiment, the formulation is free of buffering agents. |